Status:
COMPLETED
Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma
Lead Sponsor:
University Hospital, Gasthuisberg
Conditions:
Adenocarcinoma
Esophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
There has been much controversy surrounding the biologic behavior and prognosis of esophageal signet ring cell (SRCs) containing carcinomas. To clarify the biologic behavior of SRCs, the investigators...
Detailed Description
Adenocarcinoma (ADC) of the esophagus and gastroesophageal junction (GEJ) is an aggressive neoplasm and has a poor prognosis. Surgical based treatment has been the treatment of choice for localized es...
Eligibility Criteria
Inclusion
- \- Adenocarcinoma R0 resection Primary surgery
Exclusion
- \- Other histology R1 or R2 resection Neoadjuvant therapy
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT01824966
Start Date
March 1 2012
End Date
December 1 2012
Last Update
April 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Leuven; Dept. of Thoracic Surgery
Leuven, Belgium, 3000